Augmentation index assessed by applanation tonometry is elevated in Marfan syndrome

Journal of Cardiothoracic Surgery

Volumn 2, Issue 1, 2007, Pages

  Payne, Rupert A ^a   Hilling Smith, Roland C ^a   Webb, David J ^a   Maxwell, Simon R ^a   Denvir, Martin A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; VASODILATOR AGENT;

ADOLESCENT; ADULT; AORTA SINUS; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CASE CONTROL STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELASTICITY; FEMALE; FOURIER ANALYSIS; HUMAN; MALE; MANOMETRY; MARFAN SYNDROME; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PULSATILE FLOW;

ADOLESCENT; ADULT; BLOOD PRESSURE; CAROTID ARTERIES; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ELASTICITY; FEMALE; FOURIER ANALYSIS; HUMANS; MALE; MANOMETRY; MARFAN SYNDROME; MIDDLE AGED; NITROGLYCERIN; PULSATILE FLOW; SINUS OF VALSALVA; VASODILATOR AGENTS; YOUNG ADULT;

EID: 37749045831     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-2-43     Document Type: Article

References (19)

1. Dietz HC Cutting GR Pyeritz RE Maslen CL Sakai LY Corson GM Puffenberger EG Hamosh A Nanthakumar EJ Curristin SM: Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991, 352:337-339. 10.1038/352337a0 1852208
2. Loeys B Nuytinck L Delvaux I De Bie S De Paepe A: Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. Arch Intern Med 2001, 161:2447-2454. 10.1001/archinte.161.20.2447 11700157
3. Kielty CM Baldock C Lee D Rock MJ Ashworth JL Shuttleworth CA: Fibrillin: From microfibril assembly to biomechanical function. Philos Trans R Soc Lond B Biol Sci 2002, 357:207-217. 1692929 11911778 10.1098/ rstb.2001.1029
4. De Paepe A Devereux RB Dietz HC Hennekam RC Pyeritz RE: Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996, 62:417-426. 10.1002/ (SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R 8723076
5. Murdoch JL Walker BA Halpern BL Kuzma JW McKusick VA: Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 1972, 286:804-808. 5011789
6. Treasure T: Elective replacement of the aortic root in Marfan's syndrome. Br Heart J 1993, 69: 101-103. 1024933 8435232 10.1136/ hrt.69.2.101
7. Groenink M Lohuis TA Tijssen JG Naeff MS Hennekam RC van der Wall EE Mulder BJ: Survival and complication free survival in Marfan's syndrome: implications of current guidelines. Heart 1999, 82:499-504. 1760285 10490568
8. Roberts WC Honig HS: The spectrum of cardiovascular disease in the Marfan syndrome: A clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients. Am Heart J 1982, 104:115-135. 10.1016/0002-8703(82)90650-0 7046406
9. Hirata K Triposkiadis F Sparks E Bowen J Wooley CF Boudoulas H: The Marfan syndrome: Abnormal aortic elastic properties. J Am Coll Cardiol 1991, 18:57-63. 2050942
10. Jeremy RW Huang H Hwa J McCarron H Hughes CF Richards JG: Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. Am J Cardiol 1994, 74:369-373. 10.1016/ 0002-9149(94)90405-7 8059700
11. Jondeau G Boutouyrie P Lacolley P Laloux B Dubourg O Bourdarias JP Laurent S: Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation 1999, 99:2677-2681. 10338462
12. Nichols WW O'Rourke MF: McDonald's Blood Flow in Arteries - Theoretical, experimental and clinical principles. London: Arnold 1998.
13. Safar ME London GM: Therapeutic studies and arterial stiffness in hypertension: Recommendations of the European Society of Hypertension. The Clinical Committee of Arterial Structure and Function. Working Group on Vascular Structure and Function of the European Society of Hypertension. J Hypertens 2000, 18:1527-1535. 10.1097/ 00004872-200018110-00001 11081763
14. Wilkinson IB Fuchs SA Jansen IM Spratt JC Murray GD Cockcroft JR Webb DJ: Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998, 16:2079-2084. 10.1097/ 00004872-199816121-00033 9886900
15. Oliver JJ Webb DJ: Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003, 23:554-566. 10.1161/01.ATV.0000060460.52916.D6 12615661
16. Takazawa K Tanaka N Takeda K Kurosu F Ibukiyama C: Underestimation of vasodilator effects of nitroglycerin by upper limb blood pressure. Hypertension 1995, 26:520-523. 7649592
17. Kingwell BA Gatzka CD: Arterial stiffness and prediction of cardiovascular risk. J Hypertens 2002, 20:2337-2340. 10.1097/ 00004872-200212000-00006 12473851
18. Segers P De Backer J Devos D Rabben SI Gillebert TC Van Bortel LM De Sutter J De Paepe A Verdonck PR: Aortic reflection coefficients and their association with global indexes of wave reflection in healthy controls and patients with Marfan's syndrome. Am J Physiol Heart Circ Physiol 2006, 290(6):H2385-92. 10.1152/ajpheart.01207.2005 16399860
19. Nakamura M Itoh S Makita S Ohira A Arakawa N Hiramori K: Peripheral resistance vessel dysfunction in Marfan syndrome. Am Heart J 2000, 139:661-666. 10.1016/S0002-8703(00)90045-0 10740149